'Dangerous Drugs' Category
By Simmons Hanly Conroy | July 8, 2013
FDA To Revisit Rule Blocking Lawsuits Against Generic Drug Makers
The U.S. Food & Drug Administration has indicated it might allow generic drug manufacturers to revise their products’ safety labels independent of their name brand counterparts. If this change is made, consumers harmed by… Read More
By Simmons Hanly Conroy | April 29, 2013
Study Finds Januvia May Damage Pancreas
Januvia is a once-daily medication prescribed to help lower blood sugar levels in patients with type 2 diabetes. Also known by the name Sitagliptin, the medication can be used in combination with… Read More
By Simmons Hanly Conroy | February 5, 2013
Research Finds Female Lipitor Users Have Increased Risk of Diabetes
Three studies have determined women who take the cholesterol-lowering drug Lipitor have an increased risk of developing Type 2 Diabetes. In one study published by The Archives of Internal Medicine, the risk for older… Read More
By Simmons Hanly Conroy | December 31, 2012
The FDA’s Role in Dealing with Drug Shortages
When Ameridose, the company linked to the recent meningitis outbreaks and production of contaminated steroid injections closed its doors for the remainder of the year, many people worried about drug shortages. Since then, the… Read More
By Simmons Hanly Conroy | December 21, 2012
Continued Meningitis Cases Have Doctors Baffled
More than one month ago, fungal meningitis cases began appearing from the use of tainted steroid injections, resulting in a total of 37 deaths. The 42-day risk period for contracting fungal meningitis… Read More
By Simmons Hanly Conroy | December 4, 2012
The Energy Drink Craze: Is It Safe?
Are energy drinks a hazard to our health? Recent news regarding a wrongful death lawsuit involving a 14-year-old girl who died after drinking two 24-ounce cans of Monster Energy within 24 hours suggests… Read More
By Simmons Hanly Conroy | November 30, 2012
The Latest in Meningitis Outbreak News
The meningitis outbreaks that took place in October and November made headlines for much of the past month. Following the death of 32 people from the outbreaks, the FDA discovered a link… Read More
By Simmons Hanly Conroy | October 30, 2012
Pradaxa and Chantix Account for the Most Drug Complaints to the FDA
The October 2012 QuarterWatch report from the Institute for Safe Medication Practices details the number of drug complaints received by the FDA over the past four years. Prescription medication complaints issued to the FDA… Read More
By Simmons Hanly Conroy | October 25, 2012
Actos Update: Early Studies Showed Increased Risk of Bladder Cancer
Recently, the Institute for Safe Medication Practices released the October QuarterWatch report that details the increase in reports of drugs with serious adverse side effects to the FDA. It discusses type 2 diabetes drug… Read More
By Simmons Hanly Conroy | September 4, 2012
The Dangers of SSRI’s for Pregnant Women
Depression in pregnant women is not uncommon. According to this Slate.com article, depression affects more than 10 percent of all pregnant women in the U.S. In the past, many doctors prescribed pregnant women… Read More
